The advisors on Windward Bio’s series B funding round
Homburger advised Windward Bio, a private, clinical-stage biotechnology company, throughout completion of it USD 165 million series B Financing.
In connection with the round, BG Partner represented lead investor OrbiMed, Novo Holdings, Blue Owl Capital and Omega Funds.
The investor base further included existing investors SR One, RTW Investments, Qiming Venture Partners, Quan Capital, and Pivotal bioVenture Partners, as well as new investors RA Capital Management, Janus Henderson Investors, Sanofi Ventures, and Harbour BioMed.
The Homburger team
The Homburger team advising Windward Bio includes Andreas Müller, Margrit Marti, Lucas Forrer, Anina Preusker and Géraldine Bär (all corporate/M&A) as well as Stefan Oesterhelt and Juliette Buob (both tax)
The BG Partner team
The BG Partner team consisted of partner Oliver Gnehm, senior associate Victoria Marty, senior associate Tessa Douma, and associate Céline Meier.
